Are you currently dealing with Herpes (HSV)?
Did you know that there may be a link between people with immunosuppression diseases like Herpes and a new class of genetic mutations, including the KRAS-variant?
You may be eligible for one of our studies about these novel mutations and herpes, which seek to find the best ways to identify the link between these disorders and steps for prevention. Take the eligibility survey to join.
TAKE THE ELIGIBILITY SURVEY
We encourage you to see if you are eligible to join a MiraKind study to help us discover meaningful ways to better treat patients with genetic mutations. If you would like to join a study, please click the button below. You will be able to choose to get your KRAS-variant results at a discounted cost ($195) through the study. If you would prefer to directly order KRAS-variant testing at cost ($295) without joining a study, please follow this link.
MiraKind’s current research studies are designed to protect the health of individuals with these new mutations and to help answer the most pressing questions about disease and cancer.
MiraKind / 11600 Wilshire Boulevard, Los Angeles, CA 90025 / email@example.com